Decheng Capital LLC Legend Biotech Corp Transaction History

Decheng Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$27.69 - $37.91 $2.22 Million - $3.03 Million	-80,000 Reduced 80.0%	20,000 $710 Million
Q1 2025 May 07, 2025	SELL	$31.43 - $39.7 $1.68 Million - $2.13 Million	-53,558 Reduced 34.88%	100,000 $3.39 Billion
Q4 2024 Feb 14, 2025	BUY	$32.49 - $50.28 $1.46 Million - $2.26 Million	45,000 Added 41.45%	153,558 $5 Billion
Q3 2024 Nov 14, 2024	BUY	$43.55 - $59.88 $435,500 - $598,800	10,000 Added 10.15%	108,558 $5.29 Billion
Q2 2024 Aug 14, 2024	BUY	$39.5 - $57.22 $481,702 - $697,797	12,195 Added 14.12%	98,558 $4.37 Billion

Q1 2024 May 13, 2024	BUY	$55.06 - $69.99 $4.76 Million - $6.04 Million	86,363 New	86,363 $4.84 Billion

224

57.2M

231K

626K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.07B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Decheng Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Decheng Capital LLC with notifications on news.